Janakan Krishnarajah

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Gautam Goel, Tim King, A. James M. Daveson et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 144 citations · Full text

Life Sciences, Immunology, Autoimmunity +16

A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers

Patrick F. Smith, Janakan Krishnarajah, Philip A. Nunn et al. · British Journal of Clinical Pharmacology · 2017 · 102 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults

Susan B. Manoff, Michele Sausser, Amy Falk Russell et al. · Human Vaccines & Immunotherapeutics · 2018 · 70 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial

D. D. Kim, Janakan Krishnarajah, Stephen Lillioja et al. · Diabetes Obesity and Metabolism · 2015 · 62 citations

Agriculture, Pharmacology, Pharmacotherapy +17

Refined localisation of the genes for nebulin and titin on chromosome 2q allows the assignment of nebulin as a candidate gene for autosomal recessive nemaline myopathy.

Katarina Pelin, Maaret Ridanpää, Kati Donner et al. · PubMed · 1998 · 31 citations

Life Sciences, Genetics, Molecular Genetics +7